Keyphrases
Active Agent
10%
Adult Stem Cell Differentiation
10%
Biochemical Composition
10%
Cell Pellet
20%
Cell-conditioned Medium
100%
Cell-to-cell
10%
Chondrogenic
10%
Clinical Goals
10%
Collagen II
10%
Collagen III
10%
Collagen Type II
10%
Collagen Type III
10%
Decreased Expression
10%
Differentiated Mesenchymal Stem Cells
10%
Disc Cells
10%
Disc Disease
10%
DNA Expression
10%
Early Intervention
10%
Gene Expression
10%
Gene Expression Profile
10%
Glycosaminoglycans
20%
High Cell Density Culture
10%
Human Mesenchymal Stem Cells (hMSCs)
10%
Injectable Therapies
10%
Intervertebral Disc
40%
Intervertebral Disc Regeneration
30%
Laminin-1
20%
Media Control
10%
Media Treatment
10%
Mesenchymal Stem Cell Differentiation
100%
Mesenchymal Stem Cells
40%
Mesenchymal Stem Cells from Bone Marrow
10%
Mesenchymal Tissue
10%
Notochordal Cells
100%
Nucleus Pulposus
100%
Phenotype Characteristics
10%
Serum-free Medium
10%
Soluble Factors
10%
SRY-box Transcription Factor 9 (SOX9)
20%
Therapeutic Effect
10%
Tissue Inhibitor of metalloproteinase-1 (TIMP-1)
10%
Tissue-engineered Constructs
10%
Transforming Growth Factor-β
30%
Neuroscience
Cancer Growth Factor
37%
Cellular Differentiation
100%
Collagen Type 2
12%
Collagen Type 3
12%
Dexamethasone
12%
Gene Expression
25%
Glycosaminoglycan
25%
Intervertebral Disk
75%
Laminin 1
25%
Mesenchymal Stem Cell
100%
Metalloprotease Inhibitor
12%
Nucleus Pulposus
100%
Stem Cell
12%
Biochemistry, Genetics and Molecular Biology
Adult Stem Cell
12%
Biochemical Composition
12%
Cancer Growth Factor
37%
Cellular Differentiation
100%
Dexamethasone
12%
Gene Expression
25%
Glycosaminoglycan
25%
Laminin
25%
Metalloprotease Inhibitor
12%
Stem Cell
100%
Type II Collagen
12%